Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2007
06/26/2007US7235575 Guanidine mimics as factor Xa inhibitors
06/26/2007US7235571 Insecticides; for human or veterinary medicine
06/26/2007US7235570 1,4-dihydropyridine and pyridine compounds as calcium channel blockers
06/26/2007US7235569 5-HT1A receptor antagonists and serotonin uptake inhibitors; increasing levels of serotonin in synapse and reducing latency period; psychological disorders
06/26/2007US7235568 N-dihydrobenzofuran-7-yloxyethyl-substituted, e.g., [2-(2,2-Dimethyl-2,3-dihydrobenzofuran-7-yl-oxy)ethyl]-(5-cyclopenten-1-ylpyridin-3-ylmethyl)amine; benzofuran ring may 2-spirocyclopropyl- or 2-spirocyclobutyl-substituted
06/26/2007US7235566 Pyridinone derivatives for treatment of atherosclerosis
06/26/2007US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis
06/26/2007US7235562 5-trifluoromethyl-N2-indolyl- and quinolinyl-substituted-2,4-pyrimidinediamines, e.g., N2-[3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-N4-p-tolyl-5-trifluoromethyl-pyrimidine-2,4-diamine and -[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-3,4-dihydro-1H-quinolin-2-one
06/26/2007US7235561 Compound and a composition including such a compound
06/26/2007US7235560 Pyrimidine derivative as selective COX-2 inhibitors
06/26/2007US7235559 Therapeutic quinazoline derivatives
06/26/2007US7235558 Anticoagulant; cardiovascular disorders; restenosis
06/26/2007US7235555 Indolylmaleimide derivatives
06/26/2007US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
06/26/2007US7235545 (Calcitonin gene related peptide); azepinone ligands; migranes; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
06/26/2007US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease
06/26/2007US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents
06/26/2007CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them
06/21/2007WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/21/2007WO2007070818A1 Six-membered heterocycles useful as serine protease inhibitors
06/21/2007WO2007070556A2 N-(6-membered aromatic ring)-amido anti-viral compounds
06/21/2007WO2007070506A2 Diaza heterocyclic sulfonamide derivatives and their uses
06/21/2007WO2007070201A1 Aspartic protease inhibitors
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007069053A1 Benzimidazole antagonists of the h-3 receptor
06/21/2007WO2007068925A1 An improved process for preparing of, impurities free, substituted 2-benzimidazolesulfoxide compound
06/21/2007WO2007068814A1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
06/21/2007WO2007068621A1 Novel fused pyrrole derivatives
06/21/2007WO2007068552A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
06/21/2007WO2007068316A1 Hydroxyquinoline derivatives
06/21/2007WO2007048841A3 Novel indole-containing beta agonists, method for producing them and their use as drugs
06/21/2007WO2007045462A3 Novel vanilloid receptor ligands and their use for producing medicaments
06/21/2007WO2007039462A3 Indane derivatives as mch receptor antagonists
06/21/2007WO2007036532A3 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
06/21/2007WO2007035355A3 Modulators of metabolism and the treatment of disorders related thereto
06/21/2007WO2007022380A3 Bis-aryl amide compounds and methods of use
06/21/2007WO2007003604A3 Hists1mine h3 receptor antagonists
06/21/2007WO2007001466A3 Peptidomimetic somatostatin receptor subtype 2 ligands and pet imaging agents
06/21/2007WO2006123257A8 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1, 2 , 4]0xadiaz0l-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors
06/21/2007WO2006115918A3 Vla-4 antagonists
06/21/2007WO2006099942A3 Use of amino-substituted benzimidazoles
06/21/2007WO2005046318A3 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
06/21/2007US20070142640 Method for producing 1, 2-dihydropyridine-2-one compound
06/21/2007US20070142634 phenylamide and pyridylamide derivative compounds having a terminal or branched amino or hydroxyl group
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142442 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/21/2007US20070142440 Pyridinamide derivatives as kinase inhibitors
06/21/2007US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
06/21/2007US20070142431 Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists
06/21/2007US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof
06/21/2007US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
06/21/2007US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases
06/21/2007US20070142412 Crystalline form of 2-{4-['3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl]piperidin-1-yl}-2-oxoethanol
06/21/2007US20070142409 3-Substituted-4-pyrimidone derivatives
06/21/2007US20070142394 Substituted aniline derivatives useful as histamine H3 antagonists
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142391 Piperazine-2-carboxamide derivatives
06/21/2007US20070142389 Piperidine derivatives
06/21/2007US20070142388 Inhibitors of Akt activity
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
06/21/2007US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
06/21/2007US20070142373 Quinoline derivatives as phosphodiesterase inhibitors
06/21/2007US20070142371 Anti-Cytokine Heterocyclic Compounds
06/21/2007US20070142365 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC
06/21/2007US20070142360 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/21/2007US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
06/21/2007US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
06/21/2007US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R)
06/21/2007US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide
06/21/2007US20070142268 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
06/21/2007US20070142229 Agriculture
06/21/2007US20070141659 Sets and Compositions Pertaining to Analyte Determination
06/21/2007US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay
06/21/2007US20070141137 Stable capsule preparation
06/21/2007DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug
06/21/2007DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor
06/21/2007CA2637740A1 Fused pyrrole derivatives
06/21/2007CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
06/21/2007CA2633908A1 Hydroxyquinoline derivatives useful for the treatment of tumors and cellular proliferation
06/21/2007CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds
06/21/2007CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/21/2007CA2632027A1 Diaza heterocyclic sulfonamide derivatives and their uses
06/21/2007CA2631813A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
06/21/2007CA2631311A1 An improved process for preparing of, impurities free, substituted 2-benzimidazolesulfoxide compound
06/21/2007CA2628952A1 Aspartic protease inhibitors
06/20/2007EP1798231A2 Intermediate products for the preparation of antibacterial compounds
06/20/2007EP1798230A1 Substituted alkylamine derivatives and methods of use
06/20/2007EP1798229A1 Substituted biphenyl derivative
06/20/2007EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS
06/20/2007EP1797073A2 Bicyclic anilide spirolactam cgrp receptor antagonists
06/20/2007EP1797072A2 Pyrazole kinase modulators and methods of use
06/20/2007EP1797071A1 Carbonyl compounds usable as coagulation factor xa inhibitors
06/20/2007EP1797070A1 Compounds, compositions containing them, preparations thereof and uses thereof ii
06/20/2007EP1797069A2 Hiv inhibiting 5-heterocyclyl pyrimidines
06/20/2007EP1797068A1 Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines
06/20/2007EP1797067A1 New heterocyclic amides
06/20/2007EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
06/20/2007EP1797040A1 Muscarinic receptor antagonists
06/20/2007EP1797029A1 Method of deprotection
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 1080